News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,747 Results
Type
Article (76339)
Company Profile (347)
Press Release (666059)
Multimedia
Podcasts (123)
Webinars (18)
Section
Business (195373)
Career Advice (3304)
Deals (36554)
Drug Delivery (128)
Drug Development (86562)
Employer Resources (184)
FDA (16984)
Job Trends (15882)
News (345871)
Policy (35312)
Tag
Academia (2976)
Academic (1)
Accelerated approval (11)
Adcomms (32)
Allergies (105)
Alliances (50085)
ALS (119)
Alzheimer's disease (1559)
Antibody-drug conjugate (ADC) (184)
Approvals (16935)
Artificial intelligence (357)
Autoimmune disease (35)
Automation (17)
Bankruptcy (356)
Best Places to Work (12189)
BIOSECURE Act (21)
Biosimilars (135)
Biotechnology (237)
Bladder cancer (99)
Brain cancer (39)
Breast cancer (384)
Cancer (3046)
Cardiovascular disease (248)
Career advice (2802)
Career pathing (34)
CAR-T (209)
CDC (39)
Cell therapy (552)
Cervical cancer (24)
Clinical research (70847)
Collaboration (1096)
Company closure (3)
Compensation (706)
Complete response letters (33)
COVID-19 (2891)
CRISPR (66)
C-suite (350)
Cystic fibrosis (118)
Data (3068)
Decentralized trials (2)
Denatured (36)
Depression (75)
Diabetes (376)
Diagnostics (6731)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (44)
Drug discovery (150)
Drug pricing (148)
Drug shortages (36)
Duchenne muscular dystrophy (131)
Earnings (75216)
Editorial (48)
Employer branding (25)
Employer resources (161)
Events (109007)
Executive appointments (904)
FDA (18692)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (995)
Gene editing (145)
Generative AI (29)
Gene therapy (427)
GLP-1 (925)
Government (5081)
Grass and pollen (6)
Guidances (181)
Healthcare (20384)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (183)
Immuno-oncology (10)
Indications (40)
Infectious disease (3084)
Inflammatory bowel disease (164)
Inflation Reduction Act (12)
Influenza (69)
Intellectual property (124)
Interviews (626)
IPO (17170)
IRA (54)
Job creations (4102)
Job search strategy (2304)
Kidney cancer (14)
Labor market (49)
Layoffs (582)
Leadership (26)
Legal (8493)
Liver cancer (84)
Lung cancer (430)
Lymphoma (215)
Machine learning (11)
Management (64)
Manufacturing (423)
MASH (99)
Medical device (14201)
Medtech (14206)
Mergers & acquisitions (20149)
Metabolic disorders (954)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (41)
Neuroscience (2303)
NextGen: Class of 2025 (7337)
Non-profit (5017)
Now hiring (45)
Obesity (489)
Opinion (289)
Ovarian cancer (104)
Pain (120)
Pancreatic cancer (125)
Parkinson's disease (199)
Partnered (24)
Patents (315)
Patient recruitment (170)
Peanut (55)
People (58892)
Pharmaceutical (79)
Pharmacy benefit managers (25)
Phase I (21731)
Phase II (30892)
Phase III (23382)
Pipeline (1685)
Policy (235)
Postmarket research (3215)
Preclinical (9570)
Press Release (69)
Prostate cancer (146)
Psychedelics (45)
Radiopharmaceuticals (272)
Rare diseases (517)
Real estate (6322)
Recruiting (75)
Regulatory (24456)
Reports (46)
Research institute (2619)
Resumes & cover letters (525)
Rett syndrome (10)
RNA editing (9)
RSV (58)
Schizophrenia (98)
Series A (172)
Series B (118)
Service/supplier (17)
Sickle cell disease (66)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (37)
Startups (3942)
State (2)
Stomach cancer (17)
Supply chain (83)
Tariffs (61)
The Weekly (85)
Vaccines (908)
Venture capital (55)
Weight loss (325)
Women's health (50)
Worklife (20)
Date
Today (67)
Last 7 days (390)
Last 30 days (1954)
Last 365 days (32494)
2025 (17454)
2024 (36590)
2023 (41496)
2022 (52730)
2021 (57400)
2020 (56252)
2019 (50051)
2018 (38092)
2017 (35170)
2016 (34671)
2015 (39873)
2014 (32205)
2013 (30901)
2012 (30114)
2011 (30445)
2010 (29076)
Location
Africa (1055)
Alabama (64)
Alaska (7)
Arizona (198)
Arkansas (14)
Asia (44800)
Australia (7896)
California (7489)
Canada (2356)
China (721)
Colorado (330)
Connecticut (331)
Delaware (198)
Europe (104657)
Florida (1134)
Georgia (256)
Hawaii (2)
Idaho (65)
Illinois (684)
India (29)
Indiana (366)
Iowa (16)
Japan (236)
Kansas (113)
Kentucky (30)
Louisiana (17)
Maine (64)
Maryland (1055)
Massachusetts (5626)
Michigan (253)
Minnesota (456)
Mississippi (3)
Missouri (100)
Montana (32)
Nebraska (24)
Nevada (82)
New Hampshire (72)
New Jersey (2101)
New Mexico (31)
New York (2118)
North Carolina (1198)
North Dakota (10)
Northern California (3274)
Ohio (245)
Oklahoma (17)
Oregon (37)
Pennsylvania (1633)
Puerto Rico (17)
Rhode Island (39)
South America (1408)
South Carolina (35)
South Dakota (1)
Southern California (2797)
Tennessee (127)
Texas (1159)
United States (28110)
Utah (220)
Virginia (201)
Washington D.C. (79)
Washington State (655)
West Virginia (4)
Wisconsin (71)
742,747 Results for "emd group emd millipore st charles missouri".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
June 13, 2025
·
8 min read
Press Releases
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
May 23, 2025
·
19 min read
Press Releases
EMD Serono Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash
May 21, 2025
·
7 min read
Genetown
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced new research from the company’s diverse oncology portfolio will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4, Chicago.
May 23, 2024
·
32 min read
Genetown
EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced the presentation of two new post-hoc analyses of tertiary endpoints from the MAGNIFY-MS study, a Phase IV, prospective, open-label study evaluating the efficacy and safety of MAVENCLAD® tablets in highly active relapsing multiple sclerosis.
February 29, 2024
·
13 min read
Biotech Beach
EMD Serono and Takeda Join Rancho Biosciences as Charter Members of the Spatial Innovation Initiative
Rancho Biosciences is pleased to announce its partnership with EMD Serono, Takeda and a top 10 pharma company as charter members of the groundbreaking Spatial Innovation Initiative.
February 6, 2024
·
2 min read
Business
EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced that it plans to move its U.S. Healthcare headquarters, currently located in Rockland, Mass., to Boston’s Seaport district.
November 14, 2023
·
3 min read
Genetown
EMD Serono Launches New Collaboration with United Nations’ Global Initiative on Ageing to Support Caregivers
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada, announced a new collaboration with the United Nations’ Global Initiative on Ageing to provide a training course on critical skills for family caregivers.
October 5, 2023
·
4 min read
Genetown
EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
EMD Serono announced that 28 abstracts featuring the latest research on the company’s oncology portfolio addressing unmet needs across bladder, head and neck, lung, colorectal and other cancers, will be presented at the 2023 European Society of Medical Oncology Annual Meeting, October 20-24, Madrid, Spain.
October 16, 2023
·
28 min read
Genetown
EMD Serono Presents New MAVENCLAD® (Cladribine) Tablets Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced the presentation of new analyses from the MAVENCLAD® tablets MAGNIFY-MS study, which demonstrated that patients with relapsing multiple sclerosis experienced sustained reduction in serum neurofilament light chain, indicating that MAVENCLAD reduced neuronal injury over two years.
October 10, 2023
·
12 min read
1 of 74,275
Next